Suppr超能文献

庆大霉素肾毒性中近端小管溶酶体酶的改变。

Alterations in lysosomal enzymes of the proximal tubule in gentamicin nephrotoxicity.

作者信息

Olbricht C J, Fink M, Gutjahr E

机构信息

Department of Nephrology, Medical School Hannover, Germany.

出版信息

Kidney Int. 1991 Apr;39(4):639-46. doi: 10.1038/ki.1991.76.

Abstract

Gentamicin accumulates in proximal tubule lysosomes, increases their number, and changes their structure. An important lysosomal function is degradation of intracellular proteins. To evaluate the effect of gentamicin on this lysosomal function, we measured the activity of the key lysosomal proteinases, cathepsin B and L, in microdissected S1, S2, and S3 segments of rat proximal tubules by means of a fluorometric microassay. The cathepsin activities were decreased in S1 and S2 following one and four gentamicin injections of 100 mg/kg body weight. The lysosomal enzyme, acid phosphatase, was also measured and was not decreased by gentamicin. The urine excretion of cathepsins B and L was decreased after gentamicin. This excludes an increase in urinary loss of cathepsins as the cause of decreased tubule activity. Structural changes of the lysosomes per se were excluded as the factor responsible for the reduced cathepsin activity by demonstrating increased cathepsin B and L activity in proximal tubule segments from rats injected with dextran, since dextran induces an increase in number and size of proximal tubule lysosomes. In vitro incubation of urine and tubule segments with gentamicin demonstrated a concentration-dependent reversible inhibition of cathepsin B and L. We conclude that gentamicin per se decreased cathepsin B and L activities in proximal tubule segments as early as 24 hours following one injection due to either enzyme inhibition or reduced generation of active intralysosomal cathepsin B and L. Gentamicin may, therefore, reduce renal protein catabolism by decreasing the activity of the key proteolytic enzymes, cathepsin B and L. Since cathepsin B and L are proteolytic activators of other lysosomal enzymes, their reduced activity may also decrease the activities of other lysosomal enzymes.

摘要

庆大霉素积聚在近端肾小管溶酶体中,使其数量增加,并改变其结构。溶酶体的一项重要功能是降解细胞内蛋白质。为了评估庆大霉素对这种溶酶体功能的影响,我们通过荧光微量测定法测量了大鼠近端肾小管显微切割的S1、S2和S3节段中关键溶酶体蛋白酶组织蛋白酶B和L的活性。在给予100mg/kg体重的庆大霉素一次和四次注射后,S1和S2中的组织蛋白酶活性降低。还测量了溶酶体酶酸性磷酸酶,其活性未因庆大霉素而降低。庆大霉素后组织蛋白酶B和L的尿排泄减少。这排除了组织蛋白酶尿流失增加是肾小管活性降低的原因。通过证明注射葡聚糖的大鼠近端肾小管节段中组织蛋白酶B和L活性增加,排除了溶酶体本身的结构变化是组织蛋白酶活性降低的原因,因为葡聚糖会诱导近端肾小管溶酶体数量和大小增加。用庆大霉素对尿液和肾小管节段进行体外孵育显示,组织蛋白酶B和L受到浓度依赖性可逆抑制。我们得出结论,庆大霉素本身在一次注射后24小时内就降低了近端肾小管节段中组织蛋白酶B和L的活性,这是由于酶抑制或溶酶体内活性组织蛋白酶B和L的生成减少所致。因此,庆大霉素可能通过降低关键蛋白水解酶组织蛋白酶B和L的活性来减少肾脏蛋白质分解代谢。由于组织蛋白酶B和L是其他溶酶体酶的蛋白水解激活剂,它们活性的降低也可能降低其他溶酶体酶的活性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验